- Trials with a EudraCT protocol (217)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (45)
217 result(s) found for: Bioavailability.
Displaying page 1 of 11.
EudraCT Number: 2014-001222-15 | Sponsor Protocol Number: 47955 | Start Date*: 2014-07-30 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Bioavailability of voriconazole in critically ill patients | ||
Medical condition: Suspected or prophylaxis of invasive aspergillosis. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-003627-20 | Sponsor Protocol Number: NAI008/I | Start Date*: 2009-01-28 |
Sponsor Name:University of Dundee, Research & Innovation Services | ||
Full Title: Comparative Relative Lung Bioavailability of HFA-Seretide via spacer devices in healthy volunteers | ||
Medical condition: Bronchial Asthma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-001104-36 | Sponsor Protocol Number: NAI005/I | Start Date*: 2006-04-27 |
Sponsor Name:University of Dundee (Research & Innovation Services) | ||
Full Title: COMPARATIVE LUNG BIOAVAILABILITY OF HFA-SERETIDE VIA SPACER DEVICES IN HEALTHY VOLUNTEERS | ||
Medical condition: Bronchial Asthma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-001896-63 | Sponsor Protocol Number: E3810-A001-015 | Start Date*: 2016-06-27 |
Sponsor Name:Eisai Medical Research Inc. | ||
Full Title: An Ascending Bioavailability of a New Oral Suspension of E3810 | ||
Medical condition: Bioavailability/Bioequivalence | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2017-001803-57 | Sponsor Protocol Number: CLCZ696B2126 | Start Date*: 2017-08-14 |
Sponsor Name:Novartis Pharmaceuticals Corp | ||
Full Title: A randomized, study in healthy subjects to determine the bioavailability of 200 mg LCZ696 mini-tablet compared to the 200 mg LCZ696 final market image tablet | ||
Medical condition: Study in healthy subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2014-004282-25 | Sponsor Protocol Number: CHUBX2014/10 | Start Date*: 2015-03-25 |
Sponsor Name:CHU de Bordeaux | ||
Full Title: Subcutaneous route and pharmacology of metoclopramide - SOPHA-Méto | ||
Medical condition: Digestive disorder (Nausea and vomiting) in palliative care and oncology | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002865-40 | Sponsor Protocol Number: BIODYMF | Start Date*: 2015-12-08 |
Sponsor Name:Ghent University Hospital | ||
Full Title: Open label two treatment half-side comparative study to analyse difference in nasal bioavailability between MP29-02 and fluticasone propionate. | ||
Medical condition: Subjects who need to undergo septoplasty, septorhinoplasty or functional endoscopic sinus surgery unrelated to this study. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-002093-23 | Sponsor Protocol Number: 1.01 | Start Date*: 2011-09-21 |
Sponsor Name:University of Tartu | ||
Full Title: Bioavailability of oral N-acetylcysteine in different intensive care unit patient groups | ||
Medical condition: Severe neurotrauma, severe pulmonary infections and severe gastrointestinal disease (eg peritonitis, pancreatitis, ileus, major abdominal surgery etc). Need for liquefaction of viscous sputum | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: EE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-001114-14 | Sponsor Protocol Number: ST261-DS-02-002 | Start Date*: 2004-10-22 |
Sponsor Name:SIGMA-TAU | ||
Full Title: BIOAVAILABILITY AND BIOEQUIVALENCE OF TWO ORAL FORMULATION OF L-PROPIONYLCARNITINE TABLET VS SACHET IN HEALTHY VOLUNTEERS AT THE DOSE OF 2 G OPEN, RANDOMISED, TWO-WAYS CROSS-OVER, SINGLE DOSE STUDY | ||
Medical condition: BIOEQUIVALENCE /BIOAVAILABILITY STUDY | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male | |
Trial protocol: IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-011354-18 | Sponsor Protocol Number: CiclosporinPro_1_09 | Start Date*: 2010-02-16 | |||||||||||
Sponsor Name:Universitätsklinikum Essen | |||||||||||||
Full Title: Randomised, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable ... | |||||||||||||
Medical condition: prophylaxis against renal transplant rejection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005033-11 | Sponsor Protocol Number: SRx-501-01 | Start Date*: 2008-03-27 |
Sponsor Name:CombinatoRx, Inc | ||
Full Title: A Comparison Of The Safety And Bioavailability Of Modified-Release Formulations Of Levodopa-Carbidopa In Subjects With Parkinson’s Disease | ||
Medical condition: Patients with Parkinson's Disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002254-23 | Sponsor Protocol Number: VX15-809-014 | Start Date*: 2019-06-10 |
Sponsor Name:Vertex Pharmaceuticals Incorporated | ||
Full Title: A Phase 1, Randomized, Open-label Study to Evaluate the Relative Bioavailability, Food Effect, and Dose Proportionality of a Granule Formulation of Lumacaftor in Combination With Ivacaftor in Healt... | ||
Medical condition: Healthy Adult Subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2014-003151-62 | Sponsor Protocol Number: BENOS | Start Date*: 2014-10-09 |
Sponsor Name:Infectopharm Arzneimittel und Consilium GmbH | ||
Full Title: A randomised, two-period two-stage cross-over study on the relative bioavailability of two different formulations of single doses of noscapine (phase I/IV, open-label) in healthy volunteers (fasted... | ||
Medical condition: healthy subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023918-30 | Sponsor Protocol Number: SOMA-001-2010 | Start Date*: 2011-03-16 | |||||||||||
Sponsor Name:SOCIETA' ITALO BRITANNICA L. MANETTI - H.ROBERTS & C. PER AZIONI | |||||||||||||
Full Title: Pilot clinical study on the systemic bioavailability of l-thyroxine in healthy female volunteers after four weeks of topical treatment with a new formulation based on l-thyroxine | |||||||||||||
Medical condition: treatment of localized fat, accompanied by cellulite | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002012-12 | Sponsor Protocol Number: BENOS-2-L | Start Date*: 2021-12-13 |
Sponsor Name:InfectoPharm Arzneimittel und Consilium GmbH | ||
Full Title: A randomised, two-period two-stage cross-over study on the relative bioavailability of two different liquid formulations of single noscapine doses (phase I/IV, open-label) in healthy volunteers (fa... | ||
Medical condition: Healthy controls | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002880-33 | Sponsor Protocol Number: PINDEX | Start Date*: 2016-10-28 |
Sponsor Name:University of Turku | ||
Full Title: Bioavailability and pharmacokinetics of intranasal dexmedetomidine in children | ||
Medical condition: Paediatric patients scheduled for minor procedures such as intra-articular drug injections, hernia repair, bronchoscopy or magnetic resonance imaging. | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-004698-34 | Sponsor Protocol Number: ScDex_v1.0 | Start Date*: 2016-01-26 |
Sponsor Name:University Of Turku | ||
Full Title: Pharmacokinetics of subcutaneously given dexmedetomidine in healthy volunteers | ||
Medical condition: healthy volunteers are studied. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-002380-26 | Sponsor Protocol Number: Somagel | Start Date*: 2018-09-13 | |||||||||||
Sponsor Name:SOCIETÀ ITALO BRITANNICA L. MANETTI - H. ROBERTS & C. PER AZIONI | |||||||||||||
Full Title: Single-group, open study on the systemic bioavailability, safety and local tolerability of a new gel formulation of Somatoline¿ in 30 healthy women. | |||||||||||||
Medical condition: Edematous fibrosclerotic panniculopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000330-35 | Sponsor Protocol Number: HS-2012-1 | Start Date*: 2013-05-23 | |||||||||||
Sponsor Name:Medizinische Universität Graz | |||||||||||||
Full Title: Effects of Linagliptin on endothelial function and global arginine bioavailability ratio in coronary artery disease patients with early diabetes | |||||||||||||
Medical condition: Diabetes mellitus Type 2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000647-27 | Sponsor Protocol Number: Ibu19 | Start Date*: 2019-12-18 | ||||||||||||||||
Sponsor Name:Dicofarm S.p.A. | ||||||||||||||||||
Full Title: Evaluation of efficacy and bioavailability of a new pediatric formulation based on ibuprofen lysinate vs ibuprofen in the management of pain in children | ||||||||||||||||||
Medical condition: Pain on an inflammatory basis (otitis and otomastoiditis, adenite, cellulite, arthritis) and post-operative pain | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
